市场调查报告书
商品编码
1423188
2024-2032 年按类型(人工肾臟、人工心臟、人工胰臟、人工耳蜗等)和地区分類的人工器官市场报告Artificial Organs Market Report by Type (Artificial Kidney, Artificial Heart, Artificial Pancreas, Cochlear Implants, and Others), and Region 2024-2032 |
2023年全球人造器官市场规模达到206亿美元。展望未来, IMARC Group预计到2032年市场规模将达到406亿美元,2024-2032年复合年增长率(CAGR)为7.6%。精确诊断的日益普及、先进生物材料的日益采用以及技术进步是推动市场的一些关键因素。
与传统的金属、矿物和合成材料相比,生物材料具有高导电性、强度、生物相容性和生物降解性。因此,人造器官中先进生物材料的采用有所增加,这是目前推动市场成长的主要驱动力之一。除此之外,生物材料在医疗设备、组织工程、药物和基因传递、微创手术 (MIS) 和生物感测器的利用率也有所增加。除此之外,由于全球范围内器官衰竭和疾病的数量不断增加,对人造器官生物材料的需求不断增长,这对市场产生了积极影响。
报告涵盖了市场结构、主要参与者的市场份额、参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。市场结构本质上是分散的,该行业有大量国际和地区参与者。由于产品差异化和转换成本较低,人造器官产业的新进入者数量适中。然而,严格的政府政策法规以及高昂的投资成本阻碍了新进入者进入人造器官市场。
什么是人工器官?
人造器官是设计用于植入人体作为原始器官替代品的工程装置。它们是透过从移植受者处获得的各种材料製成的,例如金属、无生命聚合物、活细胞和接种干细胞的塑胶。它们广泛用作肾臟、肺臟、肝臟、心臟、人工胰臟和人工耳蜗。它们非常适合人体,因为人体的免疫系统不会排斥人造器官。它们不需要持续连接电源或任何其他固定资源来维持患有严重器官衰竭的患者。它们有助于提供健康器官的类似功能或执行特定功能。它们还帮助提供生命维持,以防止在等待移植期间即将死亡。除此之外,它还有助于透过整容修復、癌症后手术或事故改善患者的生活。由于它们可以拯救个人的生命并帮助进行活动,因此全球范围内对人造器官的需求正在增加。
COVID-19大流行的爆发为众多产业带来了严重问题,也为各国带来了前所未有的挑战。人造器官产业并未受到疫情的严重阻碍,因为这些都是必需品。该行业的生产设施或单位没有被关闭。儘管如此,在疫情初期,由于原料产业供应链中断,人造器官的製造受到了影响。与此一致的是,由于担心病毒的广泛传播,出现了劳动力短缺,这在 COVID-19 大流行的最初几个月影响了人造器官市场。除此之外,各国管理机构对道路运输制定了严格的规则和规定,阻碍了物流运输业的发展。这在短期内暂时影响了人造器官产业的供应链。此外,全球移植治疗和诊断率较低,迫使主要参与者缩减产能,并在疫情期间面临相当大的财务损失。除此之外,由于跨境限制和贸易活动(例如世界各地货物和服务的进出口)的禁令,对人造器官的需求下降。此外,与在体内植入人造器官相比,人们更关注与冠状病毒相关的治疗方案。然而,在重新开放封锁措施后,预计未来几年对人造器官的需求将会增加。
目前,由于全球器官捐赠者数量减少,对人造器官的需求不断增加,这是积极影响市场的主要因素之一。此外,由于全球范围内器官衰竭和残疾的人数不断增加,人造器官的采用不断增加,也促进了市场的成长。除此之外,医疗设备的各种技术进步,例如穿戴式技术、微晶片技术和非侵入性诊断技术,都提供了积极的市场前景。除此之外,先进生物材料在人造器官中的使用越来越多,以提供高强度、导电性和生物相容性,为行业投资者提供了利润丰厚的成长机会。此外,对非常适合改善世界各地个人生活的人造器官的需求也在增加。再加上由于习惯和生活方式的改变,大众与生活方式相关的疾病越来越多,正在推动市场的成长。与此一致的是,人们越来越倾向于透过精确诊断来监测人造器官,这正在推动市场的成长。此外,主要参与者正在将人工智慧(AI)和嵌入式感测器引入人造器官,这正在加强市场的成长。
The global artificial organs market size reached US$ 20.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032. The growing utilization of precise diagnostics, increasing adoption of advanced biomaterials, and technological advancements represent some of the key factors driving the market.
Biomaterials offer high conductivity, strength, bio-compatibility, and bio-degradability as compared to conventional metal, mineral, and synthetic-based materials. As a result, there is a rise in the adoption of advanced biomaterials in artificial organs, which currently represents one of the primary drivers contributing to the growth of the market. In addition to this, there is an increase in the utilization of biomaterials in medical devices, tissue engineering, drug and gene delivery, minimally invasive surgery (MIS), and biosensors. Apart from this, the growing demand for biomaterials in artificial organs due to the increasing number of organ failures and diseases among individuals across the globe is positively influencing the market.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented in nature with a large number of international and regional players operating in the industry. The volume of new entrants is moderate in the artificial organs industry on account of the low product differentiation and switching costs. However, stringent government policies and regulations and high investment costs hinder the entry of new entrants in the artificial organ market.
What are Artificial Organs?
Artificial organs are engineered devices designed to be implanted in a human body as an alternative to the original organ. They are manufactured through various materials, such as metals, inanimate polymers, living cells, and plastic seeded with stem cells, that are obtained from the transplant recipient. They are widely available as kidney, lung, liver, heart, and artificial pancreas, and cochlear implants. They are highly suitable for the body as the immune system of the body does not reject the artificial organ. They do not require continuous tethering to a power supply or any other stationary resource to keep patients with serious organ failure. They assist in providing similar functions of a healthy organ or performing a specific function. They also aid in offering life support to prevent imminent death while waiting for a transplant. Besides this, it is beneficial in improving the life of a patient through cosmetic restoration, post-cancer surgery or an accident. As they save the life of individuals and aid in performing activities, the demand for artificial organs is rising across the globe.
The COVID-19 pandemic outbreak has caused severe problems for numerous industries and imposed unprecedented challenges on various countries. The artificial organ industry was not severely hampered by the pandemic as these are essential products. The production facilities or units of the industry were not shut down. Although, the manufacturing of artificial organs has been affected in the initial period of the pandemic on account of the supply chain disruptions from the raw materials industry. In line with this, there was a shortage of labor due to the fear of the widespread virus, which impacted the artificial organs market in the starting months of the COVID-19 pandemic. Apart from this, governing agencies of various countries have imposed stringent rules and regulations on on-road movement, which hampered the logistical and transportation industry. This has temporarily impacted the supply chain in the short term for the artificial organs industry. Moreover, there was a lower rate of transplant treatment and diagnostic across the globe that forced key players to descale their production capacity, and they faced some considerable financial losses during the pandemic. Besides this, there was a declined demand for artificial organs on account of the cross-border restrictions and bans on trade activities, such as imports and exports of goods and services around the world. Additionally, people were more focused on the treatment options related to the coronavirus as compared to implanting artificial organs in the body. However, after the reopening of lockdown measures, the demand for artificial organs is expected to increase in the coming years.
At present, the increasing demand for artificial organs due to the decreasing number of organ donors around the world represents one of the major factors influencing the market positively. Additionally, the rising adoption of artificial organs due to the increasing number of organ failures and disabilities among individuals across the globe is contributing to the growth of the market. Apart from this, various technological advancements in medical devices, such as wearable technology, microchips technology, and non-invasive diagnostic techniques, are offering a positive market outlook. In addition to this, the increasing utilization of advanced biomaterials in artificial organs to provide high strength, conductivity, and bio-compatibility is offering lucrative growth opportunities to industry investors. Moreover, there is a rise in demand for artificial organs that are highly suitable to enhance the lives of individuals around the world. This, coupled with the growing number of lifestyle-related diseases among the masses due to the changing habits and lifestyles, is bolstering the growth of the market. In line with this, the rising preference for monitoring artificial organs by using precise diagnostics is impelling the growth of the market. Furthermore, key players are introducing artificial intelligence (AI) and embedded sensors in artificial organs, which is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial organs market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on type.
Artificial Kidney
Artificial Heart
Artificial Pancreas
Cochlear Implants
Others
The report has provided a detailed breakup and analysis of the artificial organs market based on the type. This includes artificial kidney, artificial heart, artificial pancreas, cochlear implants, and others. According to the report, artificial kidney represented the largest segment as it acts as a replacement for traditional kidneys and dialysis systems. Moreover, technological advancements, such as emergence of artificial intelligence (AI) and embedded sensors, in the artificial kidneys is propelling the growth of the market. In line with this, there is a rise in the demand for artificial kidney due to the increasing number of patients suffering from renal failure around the world. Besides this, the growing adoption of artificial kidney on account of the rising incidences of kidney diseases and low availability of kidney donors, is offering a favorable market outlook.
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for artificial organs. Some of the factors driving the North America artificial organs market included the growing prevalence of organ failures and disabilities among the masses, rising adoption for the treatment of several cancers, and increasing number of diseases and low availability of organ donors. In addition to this, key players operating in the region are introducing miniature heart pump devices that provide smart patient management for enhanced patient experience, which is contributing to the growth of the market.
Abiomed, Inc.
HeartWare International, Inc.
Edwards Lifesciences Corp
Boston Scientific Corporation
Cochlear Limited
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.